-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Bioage Labs, Lowers Price Target to $35

Benzinga·07/31/2026 20:08:09
语音播报
Needham analyst Joseph Stringer maintains Bioage Labs (NASDAQ:BIOA) with a Buy and lowers the price target from $50 to $35.